ENSG00000132170


Homo sapiens

Features
Gene ID: ENSG00000132170
  
Biological name :PPARG
  
Synonyms : P37231 / peroxisome proliferator activated receptor gamma / PPARG
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 3
Strand: 1
Band: p25.2
Gene start: 12287368
Gene end: 12434356
  
Corresponding Affymetrix probe sets: 208510_s_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000380210
Ensembl peptide - ENSP00000495840
Ensembl peptide - ENSP00000494934
Ensembl peptide - ENSP00000494873
Ensembl peptide - ENSP00000411931
Ensembl peptide - ENSP00000392285
Ensembl peptide - ENSP00000380224
Ensembl peptide - ENSP00000380221
Ensembl peptide - ENSP00000380218
Ensembl peptide - ENSP00000287820
Ensembl peptide - ENSP00000312472
Ensembl peptide - ENSP00000380195
Ensembl peptide - ENSP00000380196
Ensembl peptide - ENSP00000380205
Ensembl peptide - ENSP00000380207
NCBI entrez gene - 5468     See in Manteia.
OMIM - 601487
RefSeq - XM_011533844
RefSeq - NM_001354666
RefSeq - NM_005037
RefSeq - NM_015869
RefSeq - NM_138711
RefSeq - NM_138712
RefSeq - XM_011533841
RefSeq - XM_011533842
RefSeq - XM_011533843
RefSeq Peptide - NP_619726
RefSeq Peptide - NP_001317544
RefSeq Peptide - NP_001341595
RefSeq Peptide - NP_001341596
RefSeq Peptide - NP_005028
RefSeq Peptide - NP_056953
RefSeq Peptide - NP_619725
swissprot - E9PFV2
swissprot - E9PFJ1
swissprot - P37231
swissprot - E9PFX5
swissprot - E7EUD1
swissprot - E7EU07
swissprot - D2KUA6
swissprot - E9PFV3
Ensembl - ENSG00000132170
  
Related genetic diseases (OMIM): 609338 - Carotid intimal medial thickness 1, 609338
  604367 - Insulin resistance, severe, digenic, 604367
  601665 - Obesity, severe, 601665
  601487 - [Obesity, resistance to]
  125853 - {Diabetes, type 2}, 125853

This gene has been taged as a transcription factor by TFT
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 PPARGENSGALG00000004974Gallus gallus
 PpargENSMUSG00000000440Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
PPARA / Q07869 / peroxisome proliferator activated receptor alphaENSG0000018695152
PPARD / Q03181 / peroxisome proliferator activated receptor deltaENSG0000011203350
NR1D1 / P20393 / nuclear receptor subfamily 1 group D member 1ENSG0000012636826
NR1D2 / Q14995 / nuclear receptor subfamily 1 group D member 2ENSG0000017473826
RORC / P51449 / RAR related orphan receptor CENSG0000014336522
RORA / P35398 / RAR related orphan receptor AENSG0000006966722
RORB / Q92753 / RAR related orphan receptor BENSG0000019896321
NR5A2 / O00482 / nuclear receptor subfamily 5 group A member 2ENSG0000011683319
NR6A1 / Q15406 / nuclear receptor subfamily 6 group A member 1ENSG0000014820016
NR5A1 / Q13285 / nuclear receptor subfamily 5 group A member 1ENSG0000013693116


Protein motifs (from Interpro)
Interpro ID Name
 IPR000536  Nuclear hormone receptor, ligand-binding domain
 IPR001628  Zinc finger, nuclear hormone receptor-type
 IPR001723  Nuclear hormone receptor
 IPR003074  Peroxisome proliferator-activated receptor
 IPR003077  Peroxisome proliferator-activated receptor gamma
 IPR013088  Zinc finger, NHR/GATA-type
 IPR022590  Peroxisome proliferator-activated receptor gamma, N-terminal
 IPR035500  Nuclear hormone receptor-like domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0000122 negative regulation of transcription by RNA polymerase II ISS
 biological_processGO:0001890 placenta development ISS
 biological_processGO:0002674 negative regulation of acute inflammatory response IEA
 biological_processGO:0006351 transcription, DNA-templated IEA
 biological_processGO:0006355 regulation of transcription, DNA-templated IEA
 biological_processGO:0006357 regulation of transcription by RNA polymerase II IEA
 biological_processGO:0006367 transcription initiation from RNA polymerase II promoter TAS
 biological_processGO:0006629 lipid metabolic process TAS
 biological_processGO:0006919 activation of cysteine-type endopeptidase activity involved in apoptotic process IDA
 biological_processGO:0007165 signal transduction IDA
 biological_processGO:0007186 G-protein coupled receptor signaling pathway IEA
 biological_processGO:0007507 heart development IEA
 biological_processGO:0007584 response to nutrient TAS
 biological_processGO:0008217 regulation of blood pressure IMP
 biological_processGO:0008285 negative regulation of cell proliferation IEA
 biological_processGO:0009409 response to cold IEA
 biological_processGO:0009612 response to mechanical stimulus IEA
 biological_processGO:0010033 response to organic substance IEA
 biological_processGO:0010742 macrophage derived foam cell differentiation IDA
 biological_processGO:0010745 negative regulation of macrophage derived foam cell differentiation IDA
 biological_processGO:0010871 negative regulation of receptor biosynthetic process IDA
 biological_processGO:0010887 negative regulation of cholesterol storage IDA
 biological_processGO:0010891 negative regulation of sequestering of triglyceride IDA
 biological_processGO:0014070 response to organic cyclic compound IEA
 biological_processGO:0015909 long-chain fatty acid transport ISS
 biological_processGO:0016525 negative regulation of angiogenesis IDA
 biological_processGO:0019216 regulation of lipid metabolic process IEA
 biological_processGO:0019395 fatty acid oxidation IEA
 biological_processGO:0030224 monocyte differentiation IDA
 biological_processGO:0030308 negative regulation of cell growth IEA
 biological_processGO:0030522 intracellular receptor signaling pathway IEA
 biological_processGO:0030855 epithelial cell differentiation ISS
 biological_processGO:0031000 response to caffeine IEA
 biological_processGO:0031100 animal organ regeneration IEA
 biological_processGO:0032526 response to retinoic acid IDA
 biological_processGO:0032869 cellular response to insulin stimulus IMP
 biological_processGO:0032966 negative regulation of collagen biosynthetic process IEA
 biological_processGO:0033189 response to vitamin A IEA
 biological_processGO:0033993 response to lipid ISS
 biological_processGO:0035357 peroxisome proliferator activated receptor signaling pathway IMP
 biological_processGO:0035902 response to immobilization stress IEA
 biological_processGO:0042493 response to drug IEA
 biological_processGO:0042593 glucose homeostasis IMP
 biological_processGO:0042594 response to starvation IEA
 biological_processGO:0042752 regulation of circadian rhythm ISS
 biological_processGO:0042953 lipoprotein transport IDA
 biological_processGO:0043065 positive regulation of apoptotic process IEA
 biological_processGO:0043388 positive regulation of DNA binding IMP
 biological_processGO:0043401 steroid hormone mediated signaling pathway IEA
 biological_processGO:0043537 negative regulation of blood vessel endothelial cell migration IDA
 biological_processGO:0043627 response to estrogen IEA
 biological_processGO:0045087 innate immune response TAS
 biological_processGO:0045165 cell fate commitment ISS
 biological_processGO:0045598 regulation of fat cell differentiation IEA
 biological_processGO:0045600 positive regulation of fat cell differentiation ISS
 biological_processGO:0045713 low-density lipoprotein particle receptor biosynthetic process IDA
 biological_processGO:0045892 negative regulation of transcription, DNA-templated ISS
 biological_processGO:0045893 positive regulation of transcription, DNA-templated IMP
 biological_processGO:0045944 positive regulation of transcription by RNA polymerase II IMP
 biological_processGO:0046321 positive regulation of fatty acid oxidation IEA
 biological_processGO:0048469 cell maturation IDA
 biological_processGO:0048511 rhythmic process IEA
 biological_processGO:0048662 negative regulation of smooth muscle cell proliferation IDA
 biological_processGO:0048714 positive regulation of oligodendrocyte differentiation IEA
 biological_processGO:0050872 white fat cell differentiation ISS
 biological_processGO:0051091 positive regulation of DNA-binding transcription factor activity IDA
 biological_processGO:0051974 negative regulation of telomerase activity IEA
 biological_processGO:0055088 lipid homeostasis TAS
 biological_processGO:0060100 positive regulation of phagocytosis, engulfment IEA
 biological_processGO:0060336 negative regulation of interferon-gamma-mediated signaling pathway IMP
 biological_processGO:0060694 regulation of cholesterol transporter activity IC
 biological_processGO:0060850 regulation of transcription involved in cell fate commitment ISS
 biological_processGO:0060965 negative regulation of gene silencing by miRNA IMP
 biological_processGO:0061614 pri-miRNA transcription by RNA polymerase II IDA
 biological_processGO:0071300 cellular response to retinoic acid IEA
 biological_processGO:0071306 cellular response to vitamin E IEA
 biological_processGO:0071379 cellular response to prostaglandin stimulus IEA
 biological_processGO:0071380 cellular response to prostaglandin E stimulus IEA
 biological_processGO:0071404 cellular response to low-density lipoprotein particle stimulus IDA
 biological_processGO:0071455 cellular response to hyperoxia IEA
 biological_processGO:1901558 response to metformin IEA
 biological_processGO:1904706 negative regulation of vascular smooth muscle cell proliferation IMP
 biological_processGO:1905461 positive regulation of vascular associated smooth muscle cell apoptotic process IMP
 biological_processGO:1905563 negative regulation of vascular endothelial cell proliferation IMP
 biological_processGO:2000230 negative regulation of pancreatic stellate cell proliferation IEA
 cellular_componentGO:0005634 nucleus IDA
 cellular_componentGO:0005654 nucleoplasm TAS
 cellular_componentGO:0005737 cytoplasm IEA
 cellular_componentGO:0005829 cytosol ISS
 cellular_componentGO:0032991 protein-containing complex IDA
 cellular_componentGO:0043231 intracellular membrane-bounded organelle IDA
 cellular_componentGO:0048471 perinuclear region of cytoplasm IEA
 cellular_componentGO:0090575 RNA polymerase II transcription factor complex IDA
 molecular_functionGO:0000981 RNA polymerase II transcription factor activity, sequence-specific DNA binding NAS
 molecular_functionGO:0001046 core promoter sequence-specific DNA binding ISS
 molecular_functionGO:0003677 DNA binding ISS
 molecular_functionGO:0003682 chromatin binding ISS
 molecular_functionGO:0003690 double-stranded DNA binding IMP
 molecular_functionGO:0003700 DNA-binding transcription factor activity ISS
 molecular_functionGO:0003707 steroid hormone receptor activity IEA
 molecular_functionGO:0004879 nuclear receptor activity IDA
 molecular_functionGO:0004955 prostaglandin receptor activity TAS
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0008022 protein C-terminus binding IDA
 molecular_functionGO:0008134 transcription factor binding IPI
 molecular_functionGO:0008144 drug binding IDA
 molecular_functionGO:0008270 zinc ion binding IDA
 molecular_functionGO:0019899 enzyme binding IPI
 molecular_functionGO:0019903 protein phosphatase binding IEA
 molecular_functionGO:0030331 estrogen receptor binding IEA
 molecular_functionGO:0030374 nuclear receptor transcription coactivator activity IDA
 molecular_functionGO:0033613 activating transcription factor binding IDA
 molecular_functionGO:0042277 peptide binding IDA
 molecular_functionGO:0042802 identical protein binding IPI
 molecular_functionGO:0043565 sequence-specific DNA binding IDA
 molecular_functionGO:0043621 protein self-association IDA
 molecular_functionGO:0044212 transcription regulatory region DNA binding ISS
 molecular_functionGO:0046872 metal ion binding IEA
 molecular_functionGO:0046965 retinoid X receptor binding IPI
 molecular_functionGO:0046982 protein heterodimerization activity IDA
 molecular_functionGO:0050544 arachidonic acid binding ISS
 molecular_functionGO:0050692 DBD domain binding IDA
 molecular_functionGO:0050693 LBD domain binding IDA
 molecular_functionGO:0051393 alpha-actinin binding IPI


Pathways (from Reactome)
Pathway description
PPARA activates gene expression
Transcriptional regulation of white adipocyte differentiation
Nuclear Receptor transcription pathway
SUMOylation of intracellular receptors
Regulation of PTEN gene transcription


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000083 Renal failure 
Show

 HP:0000112 Nephropathy "A nonspecific term referring to disease or damage of the kidneys." [HPO:curators]
Show

 HP:0000141 Amenorrhea 
Show

 HP:0000147 polycystic ovaries 
Show

 HP:0000163 Abnormality of the oral cavity "Abnormality of the opening or hollow part of the mouth." [HPO:curators]
Show

 HP:0000271 Abnormality of the face 
Show

 HP:0000292 Loss of facial adipose tissue "Loss of normal subcutaneous fat tissue in the face." [HPO:curators]
Show

 HP:0000303 Mandibular prognathia "Abnormal prominence of the chin related to an abnormally long mandible." [HPO:curators]
Show

 HP:0000336 Prominent supraorbital ridges "Abnormal prominence of the supraorbital ridges, which are bony ridge located above the eye sockets in the area of the eyebrows." [HPO:curators]
Show

 HP:0000464 Abnormality of the neck 
Show

 HP:0000786 Primary amenorrhea 
Show

 HP:0000819 Diabetes mellitus 
Show

 HP:0000822 Hypertension "High blood pressure." [HPO:curators]
Show

 HP:0000826 Precocious puberty "The onset of secondary sexual characteristics before a normal age. Although it is difficult to define normal age ranges because of the marked variation with which puberty begins in normal children, precocious puberty can be defined as the onset of puberty before the age of 8 years in girls or 9 years in boys." [HPO:curators]
Show

 HP:0000831 Insulin-resistant diabetes mellitus 
Show

 HP:0000842 Hyperinsulinemia 
Show

 HP:0000845 Acromegaly "Acromegaly is a condition resulting from overproduction of growth hormone by the pituitary gland in persons with closed epiphyses, and consists chiefly in the enlargement of the distal parts of the body. The circumference of the skull increases, the nose becomes broad, the tongue becomes enlarged, the facial features become coarsened, the mandible grows excessively, and the teeth become separated. The fingers and toes grow chiefly in thickness." [HPO:curators]
Show

 HP:0000855 Insulin resistance 
Show

 HP:0000869 Secondary amenorrhea 
Show

 HP:0000876 Oligomenorrhea 
Show

 HP:0000956 Acanthosis nigricans 
Show

 HP:0000963 Thin skin 
Show

 HP:0000975 Hyperhidrosis "An abnormally increased perspiration." [HPO:probinson]
Show

 HP:0000991 Xanthomatosis "The presence of multiple xanthomas (xanthomata) in the skin. Xanthomas are yellowish, firm, lipid-laden nodules in the skin." [HPO:curators]
Show

 HP:0001000 Abnormality of skin pigmentation 
Show

 HP:0001007 Hirsutism "Abnormally increased hair growth." [HPO:curators]
Show

 HP:0001015 Prominent superficial veins 
Show

 HP:0001176 Large hands 
Show

 HP:0001249 Mental retardation 
Show

 HP:0001394 Cirrhosis 
Show

 HP:0001397 Hepatic steatosis 
Show

 HP:0001399 Hepatic failure 
Show

 HP:0001513 Obesity "A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY)." [MeSH:D009765]
Show

 HP:0001635 Congestive heart failure "The presence of an abnormality of cardiac function that is responsible for the failure of the heart to pump blood at a rate that is commensurate with the needs of the tissues or a state in which abnormally elevated filling pressures are required for the heart to do so. Heart failure is frequently related to a defect in myocardial contraction." [HPO:curators]
Show

 HP:0001639 Hypertrophic cardiomyopathy 
Show

 HP:0001658 Myocardial infarction 
Show

 HP:0001677 Coronary artery disease 
Show

 HP:0001733 Pancreatitis 
Show

 HP:0001744 Splenomegaly "An abnormal enlargement of the spleen." [HPO:curators]
Show

 HP:0001769 Broad feet "Increased width of the feet." [HPO:curators]
Show

 HP:0002092 Pulmonary hypertension 
Show

 HP:0002119 Ventriculomegaly 
Show

 HP:0002149 Hyperuricemia "An abnormally high level of uric acid in the blood." [HPO:curators]
Show

 HP:0002155 Hypertriglyceridemia 
Show

 HP:0002230 Generalized hirsutism "Abnormally increased hair growth over much of the entire body." [HPO:curators]
Show

 HP:0002240 Hepatomegaly "An abnormal enlargment of the liver." [HPO:curators]
Show

 HP:0002721 Immunodeficiency 
Show

 HP:0002757 Recurrent fractures "The repeated occurence of bone fractures (implying an abnormally increased tendency for fracture)." [HPO:curators]
Show

 HP:0003011 Abnormality of musculature "Abnormality originating in one or more muscles." [HPO:curators]
Show

 HP:0003074 Hyperglycemia 
Show

 HP:0003198 Myopathy 
Show

 HP:0003233 Decreased HDL cholesterol 
Show

 HP:0003326 Myalgia "A tendency to experience muscle pain." [HPO:curators]
Show

 HP:0003635 Loss of subcutaneous adipose tissue in limbs 
Show

 HP:0003707 Calf muscle pseudohypertrophy 
Show

 HP:0003712 Muscle hypertrophy "Hypertrophy (increase in size) of muscle cells (as opposed to hyperplasia, which refers to an increase in the number of muscle cells)." [HPO:curators]
Show

 HP:0003758 Reduced subcutaneous adipose tissue "The presence of an abnormally reduced amount of subcutaneous adipose tissue." [HPO:curators]
Show

 HP:0003812 Phenotypic variability 
Show

 HP:0005616 Accelerated skeletal maturation "An abnormally increased rate of skeletal maturation. Accelerated skeletal maturation can be diagnosed on the basis of an estimation of the bone age from radiographs of specific bones in the human body." [HPO:curators]
Show

 HP:0007457 Prominent thoracic and abdominal veins 
Show

 HP:0009017 Loss of subcutaneous adipose tissue from gluteal region 
Show

 HP:0009042 Marked muscular hypertrophy "Severe hypertrophy (increase in size) of muscle cells." [HPO:curators]
Show

 HP:0009125 Lipodystrophy "Degenerative changes of the fat tissue." [HPO:curators]
Show

 HP:0009800 maternal diabetes "Maternal diabetes can either be a gestational, mostly type 2 diabetes, or a type 1 diabetes. Essential is the resulting maternal hyperglycemia as a non-specific teratogen, imposing the same risk of congenital malformations to pregnant women with both type 1 and type2 diabetes." [HPO:curators]
Show

 HP:0009830 Peripheral neuropathy "Peripheral neuropathy is a general term for any disorder of the peripheral nervous system. The main clinical features used to classify peripheral neuropathy are distribution, type (mainly demyelinating versus mainly axonal), duration, and course." [HPO:curators]
Show

 HP:0010982 Polygenic inheritance "A type of multifactorial inheritance governed by the simultaneous action of many (more than three) gene loci." [HPO:probinson, ISBN:978-0192628961]
Show

 HP:0012062 Bone cyst "A fluid filled cavity that develops with a bone." [HPO:probinson]
Show

 HP:0012084 Abnormality of skeletal muscle fiber size "Any abnormality of the size of the `skeletal muscle cell` (FMA:9727)." [HPO:probinson]
Show

 HP:0012273 Increased carotid artery intimal medial thickness "An increase in the combined thickness of the intima and media of the carotid artery." [HPO:probinson, pmid:9878640]
Show

 HP:0012340 Decreased resting energy expenditure "An reduction in the number of calories used per unit time." [HPO:probinson]
Show

 HP:0100545 Arterial stenosis 
Show

 HP:0100578 Lipoatrophy "Localized loss of fat tissue." [HPO:sdoelken]
Show

 HP:0100601 Ecplampsia "An acute and life-threatening complication of pregnancy, which is characterized by the appearance of tonic-clonic seizures, usually in a patient who had developed pre-eclampsia. Eclampsia includes seizures and coma that happen during pregnancy but are not due to preexisting or organic brain disorders." [HPO:sdoelken]
Show

 HP:0100602 Preecplampsia "Pregnancy-induced hypertension in association with significant amounts of protein in the urine." [HPO:sdoelken]
Show

 HP:0100607 Dysmenorrhea 
Show

 HP:0100820 Glomerulopathy "Inflammatory or noninflammatory diseases affecting the glomeruli of the nephron." [HPO:sdoelken]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000196498 NCOR2 / Q9Y618 / nuclear receptor corepressor 2  / complex / reaction
 ENSG00000141027 NCOR1 / O75376 / nuclear receptor corepressor 1  / complex / reaction
 ENSG00000116030 SUMO1 / P63165 / small ubiquitin-like modifier 1  / reaction / complex
 ENSG00000186350 RXRA / P19793 / retinoid X receptor alpha  / complex / reaction
 ENSG00000103275 UBE2I / P63279 / ubiquitin conjugating enzyme E2 I  / reaction
 ENSG00000171720 HDAC3 / O15379 / histone deacetylase 3  / reaction / complex






 

1 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr